Cancers and their treatments can cause debilitating neurologic symptoms, including seizure, stroke, neuropathy and cognitive effects. Treating these symptoms can be challenging - they can easily be misdiagnosed and sometimes occur even before cancer is detected.
The John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 U.S. News and World Report "Best Hospitals for Cancer," has launched The Brain & Spine Institute to coordinate cutting-edge clinical care and research for primary and metastatic tumors as well as the varied neurologic complications of cancer.
"The brain acts as the control center for thought, memory, emotion, sensation and movement, and as a result, the effects of this particular cancer can be especially devastating and complex," said Dr. Geroge Kaptain, M.D., co-chief, The Brain & Spine Institute. "Our Institute treats these complex cases using a multidisciplinary approach comprised of experts in neuro-oncology, neurosurgery, radiation oncology, behavioral health, neuro-radiology and oncology nursing."
The Brain & Spine Institute is jointly led by neuro-oncologist Samuel A. Goldlust, M.D., who recently joined the staff from Memorial Sloan-Kettering Cancer Center and leading neurosurgeon George Kaptain, M.D., who has subspecialty training and 10 years of experience in neuro-oncology and skull-based surgery. This comprehensive care focuses on treating the whole person offering psychosocial and nutritional support, free yoga classes for patients, and educational programs.
"From the moment you walk through the door, our team of experts will guide your care with a comprehensive approach all under the same roof," said Goldlust. "We deliver our care in a brand new 155,000-square-foot treatment center designed to help patients and their families feel comfortable and secure."
For more information or to schedule a visit to The Brain and Spine Institute, log on to jtcancercenter.org/brainandspine or call 201-996-5900. Let us show you how we can be your team, before, during and after cancer treatment.
